TrialBritish journal of cancer1996

Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.

A R Hanauske et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.